Clinical Trials Logo

Iron Deficiency Anemia clinical trials

View clinical trials related to Iron Deficiency Anemia.

Filter by:

NCT ID: NCT00802139 Completed - Clinical trials for Iron Deficiency Anemia

Efficacy and Safety Study of Iron Sucrose and Oral Iron Acetyl-transferrin Hydroglycerin

Start date: February 2008
Phase: Phase 4
Study type: Interventional

multi-center, prospective, randomized, open-labeled, active-drug-controlled, two-parallel-group-comparison(venoferrun group vs Bolgre group)study

NCT ID: NCT00741143 Completed - Clinical trials for Iron Deficiency Anemia

Effect of Iron Fortified Wheat Flour on Cognition and Iron Status in Indian School Children

Start date: August 2007
Phase: N/A
Study type: Interventional

This study is designed to evaluate the efficacy of NaFeEDTA-fortified whole wheat flour in improving cognition, hemoglobin, iron status and total body iron among school children in urban Bangalore.

NCT ID: NCT00727545 Completed - Clinical trials for Iron Deficiency Anemia

Effect of Rice Fortification With Iron on Anemia Among Children

Start date: March 2006
Phase: Phase 2/Phase 3
Study type: Interventional

This was a double-blind community-based trial, placebo controlled. During 16 weeks, children in the intervention group (GI, n=180) received iron fortified rice, and children in the control group (GC, n=174) received rice with placebo. Anemia was considered present when hemoglobin < 11.0g/dL. Comparison of mean variation on hemoglobin between groups was accessed by using Student's t-test. Hemoglobin concentration improved in both groups, with mean increase of 0.42 g/dL in GI (11.28±1.23 g/dL to 11.75±1.16 g/dL, p < 0.001), and 0.49 g/dL in GC (11.06±1.13 g/dL to 11.51±1.16 g/dL, p < 0.001). Anemia decreased (p < 0.01) in both groups (37.8% to 23.3% in GI and 45.4% to 33.3% in GC), with no differences between them. Hemoglobin increase was significantly higher in children who received total amount of iron ≥ 53.76 mg from fortified rice, compared to those who received less than this cut-off value (0.94 g/dl vs 0.39 g/dl p=0.03). The results suggest that this type of intervention can be useful in anemia control if fortified food intake is adequate.

NCT ID: NCT00694954 Completed - Clinical trials for Iron Deficiency Anemia

Capsule Endoscopy vs Standard of Care for Obscure Intestinal Bleeding

Start date: February 2007
Phase: N/A
Study type: Interventional

The role of capsule endoscopy (CE) in patients with obscure / occult gastrointestinal (GI) bleeding remains unclear. This pragmatic randomized controlled trial is designed to determine the diagnostic yield and clinical outcomes of patients with obscure GI bleeding who receive CE compared to those who receive usual standard care.

NCT ID: NCT00668694 Completed - Clinical trials for Iron Deficiency Anemia

Iron Deficiency Anemia and Psychosocial Stimulation

IDA
Start date: October 2007
Phase: N/A
Study type: Interventional

In developing countries, poor nutrition, high morbidity, poverty, poor parental education and stimulation in the home, all detrimentally affect children's development. These conditions frequently occur together increasing the risk of poor development. Iron deficiency anemia (IDA) affects large numbers of young children and is associated with poor child development. There is some question as to whether infants with IDA can catch up in mental development to non-IDA infants. We plan to examine the effect of psychosocial stimulation on IDA children's growth and development using a randomized controlled trial and compare them with non-anemic children. The study will be located in poor villages accessible to Dhaka. Villages will be randomized to either receive psychosocial stimulation or none. Children, aged 6-12 months, with IDA (hemoglobin (Hb) 80.0-109g/L, ferritin<12μg/L & Transferrin Recepter (TfR) >7) (n=212) or without anemia (Hb>109g/L, ferritin>12μg/L, C-reactive protein (CRP) <5 & TfR<7) (n=212) will be identified in those villages. Intervention will include weekly home visits for 9 months by a play leader, who will demonstrate play with home made toys and teach the mothers about child development. All IDA children will be given 30 mg ferrous-sulphate daily for 9 months. At the beginning and end of the study, the following measurements will be made: Bayley Scales of Infant Development (mental and motor indices), Wolke's behavior ratings, Hb, serum ferritin, CRP, Transferrin receptor, anthropometry, home stimulation, and mothers' knowledge and practices of child development. Stool microscopy, maternal-urinary iodine (as a proxy to assess children's iodine status), dietary history, child rearing practices (parenting) of mothers, perinatal history and socioeconomic conditions will be assessed at the beginning and children's language development at the end. Depending on availability of funds serum TSH will also be measured in children to exclude iodine deficiency. We will also measure mothers' nutritional and mental status to assess its relationship with children's development. The treatment effect will be examined by intention to treat analysis using multiple regression of the outcome variables controlling for initial measures and multilevel analysis will be conducted to control for differences at village level. The findings of this project will have implications both for international and national policies on early childhood development programs for IDA children.

NCT ID: NCT00642863 Completed - Clinical trials for Iron Deficiency Anemia

Brain and Behavior Depending on Timing of Iron Deficiency in Human Infants

Start date: April 2008
Phase: N/A
Study type: Interventional

It is common in many populations that babies develop iron deficiency or iron deficiency anemia (that is, too few healthy red blood cells due to lack of iron). This is due to rapid growth in infancy combined with limited sources of iron in the infant diet. The amount of iron the baby receives across the placenta during pregnancy is another important factor. This study focuses on infants who are born with less than the usual amount of iron in their bodies. The purposes of the study are to assess effects of lower iron at birth on infant behavior and development and to determine if providing iron supplements to such infants beginning at 6 weeks fosters healthier development. Another part of the study will determine the effects of iron deficiency anemia at different times during infant development.

NCT ID: NCT00613717 Completed - Clinical trials for Iron Deficiency Anemia

Healthy Infant Development Project

Start date: November 2009
Phase: N/A
Study type: Interventional

The Healthy Infant Development Project will determine if providing micronutrient supplements to mothers during pregnancy and infants in the first 9 months fosters healthy behavior and development in babies.

NCT ID: NCT00535561 Completed - Clinical trials for Iron Deficiency Anemia

Iron Deficiency Anemia Can be an Indication for Treatment of Subclinical Hypothyroidism

Start date: June 2007
Phase: Phase 1
Study type: Interventional

To determine whether iron deficiency anemia can be an indication for the treatment of subclinical hypothyroidism.

NCT ID: NCT00520780 Completed - Clinical trials for Chronic Heart Failure

Ferinject® Assessment in Patients With Iron Deficiency and Chronic Heart Failure (FAIR-HF)

FAIR-HF
Start date: April 2007
Phase: Phase 3
Study type: Interventional

This study is designed to evaluate the efficacy of Ferinject® in improving symptoms of CHF in patients with iron deficiency. Analyses will focus both on subjective and objective measures. Furthermore, the tolerability and safety of Ferinject® treatment will be evaluated.

NCT ID: NCT00399191 Completed - Clinical trials for Iron Deficiency Anemia

A Test of Iron Malabsorption in Patients With Iron Deficiency Anemia

Start date: August 2006
Phase: Phase 1
Study type: Interventional

The objective of the study is to develop a simple, noninvasive test for evaluation of iron absorption as a tool to determine the cause of iron deficiency anemia. Healthy, premenopausal women with iron deficiency with or without anemia will be recruited for the study. Participants will, over the course of two months, ingest an iron solution three times; after each iron ingestion, participants will collect their stool and bring it to the study investigators for assessment of iron content.